Unpacking Mechanistic Insights to Strengthen Microbiome Therapeutic Development
- Explore how AOBiome Therapeutics’ recent metabolomic and preclinical work is shaping a deeper understanding of therapeutic action in dermatological indications
- Share lessons learned from bridging mechanistic hypotheses with clinical trial design to improve signal detection and separate from placebo
- Discuss how mechanistic clarity can inform formulation and delivery strategies, and open doors to new indications